z-logo
open-access-imgOpen Access
Hemoglobinopathy correction with CRISPR or not; Gene therapy is the solution
Author(s) -
Bader Al Alwan,
Arwa Alsubait,
Bahauddeen M. Alrfaei
Publication year - 2020
Publication title -
journal of nature and science of medicine
Language(s) - English
Resource type - Journals
eISSN - 2589-6288
pISSN - 2589-627X
DOI - 10.4103/jnsm.jnsm_59_19
Subject(s) - hemoglobinopathy , genetic enhancement , thalassemia , disease , medicine , crispr , genetics , gene , bioinformatics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here